| Previous Close | 2.25 |
| Open | 2.28 |
| Volume | 127,205 |
| Avg. Volume (3M) | 284,664 |
| Market Cap | 81,416,552 |
| Price / Earnings (TTM) | 5.33 |
| Price / Earnings (Forward) | 6.20 |
| Price / Sales | 0.430 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2026 |
| Profit Margin | 10.55% |
| Operating Margin (TTM) | 19.78% |
| Diluted EPS (TTM) | 0.580 |
| Quarterly Revenue Growth (YOY) | 4.70% |
| Quarterly Earnings Growth (YOY) | -52.10% |
| Current Ratio (MRQ) | 1.42 |
| Operating Cash Flow (TTM) | 44.34 M |
| Levered Free Cash Flow (TTM) | 54.17 M |
| Return on Assets (TTM) | 16.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | Biote Corp. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 3.5 |
| Average | 0.50 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 13.02% |
| % Held by Institutions | 65.98% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Globeflex Capital L P | 31 Mar 2026 | 272,400 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |